San Francisco California based Ambagon Therapeutics is raising $84,999,994.00 in New Equity Investment.
San Francisco, CA – According to filings with the U.S. Securities and Exchange Commission, Ambagon Therapeutics is raising $84,999,994.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Scott Clarke played…
